| Ricardo Salas, | |
|
4500 Morning Dr Ste 105, Bakersfield, CA 93306-7276 | |
| (661) 491-5060 | |
| (844) 742-2324 |
| Full Name | Ricardo Salas |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 13 Years |
| Location | 4500 Morning Dr Ste 105, Bakersfield, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497045355 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A122722 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Health Bakersfield | Bakersfield, CA | Hospital |
| Adventist Health Tehachapi Valley | Tehachapi, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| San Joaquin Community Hospital | 1557390580 | 80 |
News Archive
Lymphotoxin is a cytokine, or intercellular messenger, and plays an important role in the immunological balance of the gastrointestinal tract. It regulates the immune system of the digestive tract, which is made up of immune cells, immunoglobulins (antibodies) as well as intestinal bacteria.
Bacterin International, Inc., a Nevada company, today announced that it has completed a reverse merger transaction with Bacterin International Holdings, Inc. f/k/a K-Kitz, in which the Company caused its wholly-owned subsidiary to be merged with and into Bacterin, with Bacterin as the surviving company.
Archimedes Pharma US Inc. today announced publication of results from a pivotal clinical study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain (BTCP).
Omeros Corporation today announced that it has secured a committed equity financing facility under which it may sell up to $40 million of its shares of common stock to Azimuth Opportunity, Ltd. over a 24-month period. Omeros is not obligated to use the facility and remains free to enter into and consummate other equity, debt and non-dilutive financing transactions. Omeros intends to use the proceeds from future sales of securities under the facility, if any, for general corporate purposes.
UMass Medical School and UMass Lowell will perform a key role in a new National Institutes of Health initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies via their Center for Advancing Point of Care Technologies collaboration.
› Verified 8 days ago
| Entity Name | Adventist Health Physicians Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063718583 PECOS PAC ID: 3274580972 Enrollment ID: O20050407000633 |
News Archive
Lymphotoxin is a cytokine, or intercellular messenger, and plays an important role in the immunological balance of the gastrointestinal tract. It regulates the immune system of the digestive tract, which is made up of immune cells, immunoglobulins (antibodies) as well as intestinal bacteria.
Bacterin International, Inc., a Nevada company, today announced that it has completed a reverse merger transaction with Bacterin International Holdings, Inc. f/k/a K-Kitz, in which the Company caused its wholly-owned subsidiary to be merged with and into Bacterin, with Bacterin as the surviving company.
Archimedes Pharma US Inc. today announced publication of results from a pivotal clinical study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain (BTCP).
Omeros Corporation today announced that it has secured a committed equity financing facility under which it may sell up to $40 million of its shares of common stock to Azimuth Opportunity, Ltd. over a 24-month period. Omeros is not obligated to use the facility and remains free to enter into and consummate other equity, debt and non-dilutive financing transactions. Omeros intends to use the proceeds from future sales of securities under the facility, if any, for general corporate purposes.
UMass Medical School and UMass Lowell will perform a key role in a new National Institutes of Health initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies via their Center for Advancing Point of Care Technologies collaboration.
› Verified 8 days ago
| Entity Name | San Joaquin Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538157508 PECOS PAC ID: 1557390580 Enrollment ID: O20050810000537 |
News Archive
Lymphotoxin is a cytokine, or intercellular messenger, and plays an important role in the immunological balance of the gastrointestinal tract. It regulates the immune system of the digestive tract, which is made up of immune cells, immunoglobulins (antibodies) as well as intestinal bacteria.
Bacterin International, Inc., a Nevada company, today announced that it has completed a reverse merger transaction with Bacterin International Holdings, Inc. f/k/a K-Kitz, in which the Company caused its wholly-owned subsidiary to be merged with and into Bacterin, with Bacterin as the surviving company.
Archimedes Pharma US Inc. today announced publication of results from a pivotal clinical study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain (BTCP).
Omeros Corporation today announced that it has secured a committed equity financing facility under which it may sell up to $40 million of its shares of common stock to Azimuth Opportunity, Ltd. over a 24-month period. Omeros is not obligated to use the facility and remains free to enter into and consummate other equity, debt and non-dilutive financing transactions. Omeros intends to use the proceeds from future sales of securities under the facility, if any, for general corporate purposes.
UMass Medical School and UMass Lowell will perform a key role in a new National Institutes of Health initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies via their Center for Advancing Point of Care Technologies collaboration.
› Verified 8 days ago
| Entity Name | Kern County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376623538 PECOS PAC ID: 4688964521 Enrollment ID: O20160915002690 |
News Archive
Lymphotoxin is a cytokine, or intercellular messenger, and plays an important role in the immunological balance of the gastrointestinal tract. It regulates the immune system of the digestive tract, which is made up of immune cells, immunoglobulins (antibodies) as well as intestinal bacteria.
Bacterin International, Inc., a Nevada company, today announced that it has completed a reverse merger transaction with Bacterin International Holdings, Inc. f/k/a K-Kitz, in which the Company caused its wholly-owned subsidiary to be merged with and into Bacterin, with Bacterin as the surviving company.
Archimedes Pharma US Inc. today announced publication of results from a pivotal clinical study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain (BTCP).
Omeros Corporation today announced that it has secured a committed equity financing facility under which it may sell up to $40 million of its shares of common stock to Azimuth Opportunity, Ltd. over a 24-month period. Omeros is not obligated to use the facility and remains free to enter into and consummate other equity, debt and non-dilutive financing transactions. Omeros intends to use the proceeds from future sales of securities under the facility, if any, for general corporate purposes.
UMass Medical School and UMass Lowell will perform a key role in a new National Institutes of Health initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies via their Center for Advancing Point of Care Technologies collaboration.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ricardo Salas, Dept La 24522, Pasadena, CA 91185-4522 Ph: (661) 491-5060 | Ricardo Salas, 4500 Morning Dr Ste 105, Bakersfield, CA 93306-7276 Ph: (661) 491-5060 |
News Archive
Lymphotoxin is a cytokine, or intercellular messenger, and plays an important role in the immunological balance of the gastrointestinal tract. It regulates the immune system of the digestive tract, which is made up of immune cells, immunoglobulins (antibodies) as well as intestinal bacteria.
Bacterin International, Inc., a Nevada company, today announced that it has completed a reverse merger transaction with Bacterin International Holdings, Inc. f/k/a K-Kitz, in which the Company caused its wholly-owned subsidiary to be merged with and into Bacterin, with Bacterin as the surviving company.
Archimedes Pharma US Inc. today announced publication of results from a pivotal clinical study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain (BTCP).
Omeros Corporation today announced that it has secured a committed equity financing facility under which it may sell up to $40 million of its shares of common stock to Azimuth Opportunity, Ltd. over a 24-month period. Omeros is not obligated to use the facility and remains free to enter into and consummate other equity, debt and non-dilutive financing transactions. Omeros intends to use the proceeds from future sales of securities under the facility, if any, for general corporate purposes.
UMass Medical School and UMass Lowell will perform a key role in a new National Institutes of Health initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies via their Center for Advancing Point of Care Technologies collaboration.
› Verified 8 days ago
Marsha Cheng, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2400 Wible Rd Ste 14, Bakersfield, CA 93304 Phone: 661-835-1240 Fax: 661-835-4667 | |
Sarah Dowda, NP Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 8327 Brimhall Rd Ste 704, Bakersfield, CA 93312 Phone: 661-829-7677 Fax: 661-679-6920 | |
Peter Alagona Jr., M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 5020 Commerce Dr, Bakersfield, CA 93309 Phone: 661-324-4100 Fax: 661-324-4600 | |
Paramvir Singh Rahal, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9802 Stockdale Hwy, Ste 102, Bakersfield, CA 93311 Phone: 661-323-1200 Fax: 661-616-5339 | |
Harieet Singh, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2415 Niles St, Bakersfield, CA 93306 Phone: 661-631-1591 Fax: 661-631-1594 | |
Bruce G Dains, PAC Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2701 Chester Ave, Highgrove Medical Center, Bakersfield, CA 93301 Phone: 661-326-1600 Fax: 661-323-2307 | |
Dr. Oscar W. Rico, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 9001 Stockdale Hwy, 28 Hc, Bakersfield, CA 93311 Phone: 661-654-2395 |